Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
CC transcript

Obagi Medical Products, Inc. (OMPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/13/2013 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 0% stake in Obagi Medical Products, Inc.
05/10/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/06/2013 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
04/26/2013 8-K Quarterly results
04/26/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/26/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/25/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
04/25/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
04/24/2013 10-K/A Annual Report for the period ended April 23, 2013 [amend]
04/23/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
04/22/2013 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
04/17/2013 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
03/28/2013 SC 13D Obagi Medical Products, Inc. reports a 6.3% stake in Obagi Medical Products, Inc.
03/25/2013 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
03/20/2013 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
03/20/2013 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
03/20/2013 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, among Valeant Pharmaceuticals International, Odysseus Acquisition Corp., Valeant Pharmaceuticals International, Inc. and Obagi Medical Products, Inc",
"Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. For $19.75 per Share in Cash"
03/14/2013 10-K Annual Report for the period ended March 14, 2013
03/14/2013 8-K Quarterly results
Docs: "Obagi Medical Products Reports Fourth Quarter and Year-End 2012 Financial Results"
03/08/2013 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/12/2013 SC 13G/A Obagi Medical Products, Inc. reports a 5.9% stake in Obagi Medical Products, Inc.
12/10/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/03/2012 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
11/01/2012 10-Q Quarterly Report for the period ended September 30, 2012
11/01/2012 8-K Quarterly results
Docs: "Obagi Medical Products Reports Third Quarter 2012 Earnings; Company Provides Update to Key Initiatives --Conference Call To Be Held at 4:30 PM EDT Today--"
10/29/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "CONFIDENTIAL SETTLEMENT AND RELEASE"
09/10/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
09/04/2012 10-K/A Annual Report for the period ended December 31, 2011 [amend]
08/16/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Obagi Medical Products Appoints Mark Taylor as Senior Vice President Corporate Development and Investor Relations"
08/07/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
08/02/2012 10-Q Quarterly Report for the period ended June 30, 2012
08/02/2012 8-K Quarterly results
Docs: "OBAG MEDICAL PRODUCTS EARNINGS RELEASE"
08/02/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "KRISTINA M. LESLIE JOINS BOARD OF DIRECTORS OF OBAGI MEDICAL PRODUCTS"
07/10/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy